Intra-Cellular Therapies Net Worth 2013-2022 | ITCI
Interactive chart of historical net worth (market cap) for Intra-Cellular Therapies (ITCI) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Intra-Cellular Therapies net worth as of July 01, 2022 is $5.2B.
||Medical - Biomedical and Genetics
Intra-Cellular Therapies Inc. is a biopharmaceutical company. The company develops drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the central nervous system. Its product candidates include ITI-007, ITI-002 and ITI-009 which is in clinical trials. Intra-Cellular Therapies Inc. is headquartered in New York.